Physician profile
Judith Crowell
NPI 1659376218
$17,079.62
in general payments reported to CMS, 2019-2025
50 companies · $2,426 in 2025
The $2,426 reported for 2025 was more than what 80% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,965 · 2020: $1,390 · 2021: $1,877 · 2022: $2,539 · 2023: $3,104 · 2024: $2,778 · 2025: $2,426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,158 · Education: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,157.83 |
| Education | $150.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $2,340.40 | 2020-2025 | Tremfya, Simponi, Stelara |
| Abbvie INC. | $1,880.39 | 2019-2025 | Skyrizi, Rinvoq, Botox |
| Lilly USA, LLC | $1,080.74 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Pfizer INC. | $1,076.59 | 2019-2025 | |
| Galderma Laboratories, L.P. | $849.72 | 2019-2025 | Nemluvio, Aklief |
| Regeneron Healthcare Solutions, INC. | $770.92 | 2019-2025 | Dupixent, Libtayo |
| E.R. Squibb & Sons, L.L.C. | $634.61 | 2022-2025 | Sotyktu |
| Genzyme Corporation | $581.49 | 2019-2025 | |
| Ucb, INC. | $567.29 | 2019-2025 | Bimzelx, Cimzia |
| Novartis Pharmaceuticals Corporation | $548.68 | 2019-2025 | |
| Leo Pharma INC. | $524.67 | 2019-2025 | Adbry, Anzupgo |
| Promius Pharma LLC | $500.00 | 2019 | |
| Arcutis Biotherapeutics, INC. | $487.43 | 2023-2025 | Zoryve |
| Sun Pharmaceutical Industries INC. | $454.37 | 2019-2024 | Ilumya, Blu-U |
| Amgen INC. | $440.38 | 2021-2025 | Otezla, Otezla |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $425.21 | 2019-2023 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $391.65 | 2019-2025 | Jublia, Arazlo, Cabtreo |
| Incyte Corporation | $369.13 | 2021-2025 | Opzelura |
| Merz North America, INC. | $364.20 | 2019 | |
| Vyne Pharmaceuticals INC. | $320.06 | 2020-2021 | |
| Biofrontera INC. | $242.55 | 2019-2025 | Ameluz, Xepi, Bf-Rhodoled |
| Journey Medical Corporation | $241.51 | 2019-2023 | |
| Allergan, INC. | $234.88 | 2019-2022 | |
| Janssen Scientific Affairs, LLC | $234.58 | 2019-2022 | |
| Strata Skin Sciences, INC. | $219.64 | 2019-2025 | Xtrac |
| Almirall LLC | $161.12 | 2019-2025 | Seysara, Klisyri |
| Dermira, INC. | $142.24 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $112.40 | 2022-2025 | Spevigo |
| Epi Health, LLC | $84.61 | 2019-2022 | |
| Verrica Pharmaceuticals INC. | $79.34 | 2023-2025 | Ycanth |
| Encore Dermatology INC. | $78.67 | 2019-2020 | |
| Kyowa Kirin, INC. | $74.91 | 2021-2025 | Poteligeo |
| Helsinn Therapeutics (U.S.), INC. | $68.31 | 2021-2025 | Valchlor |
| Sebela Pharmaceuticals INC. | $67.32 | 2019-2022 | |
| Medimetriks Pharmaceuticals, INC. | $64.01 | 2019-2020 | |
| Kerecis Limited | $55.67 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Dermavant Sciences, INC. | $54.81 | 2023-2024 | Vtama |
| Celgene Corporation | $51.79 | 2019 | |
| Organogenesis INC. | $40.16 | 2021 | |
| Aclaris Therapeutics, INC. | $23.80 | 2019 | |
| Botanix Sb INC | $20.90 | 2025 | Sofdra |
| Smith+Nephew, INC. | $20.00 | 2022 | |
| Dusa Pharmaceuticals, INC. | $18.91 | 2019 | |
| Tempus Ai, INC | $17.03 | 2024 | Merlin Test |
| Paratek Pharmaceuticals, INC. | $16.25 | 2024 | Nuzyra |
| Mylan Pharmaceuticals INC. | $15.57 | 2019 | |
| Acera Surgical, INC. | $13.33 | 2022 | |
| Glenmark Therapeutics INC. | $12.00 | 2019 | |
| Organon LLC | $5.38 | 2025 | Vtama |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Crowell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.